Robert waltermire joins madrigal pharmaceuticals as chief pharmaceutical development officer

Conshohocken, pa., aug. 02, 2021 (globe newswire) -- madrigal pharmaceuticals, a clinical-stage biopharmaceutical company pursuing novel therapeutics for cardio-metabolic and fatty liver diseases with high unmet medical need, announced today that dr. robert

MDGL Ratings Summary

MDGL Quant Ranking